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Abstract
Objective—To evaluate correlates of vaginal intercourse without barrier contraception
(unprotected intercourse).
Study Design— Baseline data from a randomized trial were analyzed to evaluate factors associated
with intercourse without barrier method use among women under 35 years old. Logistic regression
models provided estimates of the association of demographic, reproductive, and sexual history
variables with unprotected intercourse.
Results— Intercourse without barrier contraception was common: 65% of participants had two or
more episodes of intercourse without barrier contraception use in the past month. Factors associated
with increased odds of unprotected intercourse included: number of coital episodes, partner’s
unwillingness to use condoms (Odds Ratio (OR)adj 4.1, 95%Confidence Interval (CI) 2.3–6.9), and
among women under 20 years, low condom use self-efficacy score (ORadj 1.6, 95%CI 1.0–2.9).
Conclusion— Risk factors for unprotected intercourse included coital frequency and the male
partner’s unwillingness to use condoms. Self-efficacy for condom use was especially important for
women under 20 years of age.
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Condom use; barrier contraceptive method; sexually transmitted disease; sexually transmitted
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CONDENSATION
Vaginal intercourse without barrier contraception was common in this cohort of high-risk women, and factors associated with lack of
barrier use varied by age group.
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INTRODUCTION
Unintended pregnancy, sexually transmitted diseases (STDs) and the adverse health
consequences of STDs are widespread public health problems in the United States and
worldwide. An estimated 18.9 million new STD infections, both curable and incurable, occur
each year in the United States. 1 Women suffer the adverse effects of STDs to a greater degree
than men. 2 Thus, it is important to identify methods of prevention to advance women’s health
in the U.S.
Barrier contraceptive methods (specifically male condoms), when used consistently and
correctly, are effective in preventing numerous STDs, including the human immunodeficiency
virus (HIV). 3 In 2000, the NIH released a landmark report of the effectiveness of condoms
for prevention. The report, Scientific Evidence on Condom Effectiveness for Sexually
Transmitted Disease (STD) Prevention, summarized the published studies on condom
effectiveness as of June 2000. 4 The report stated that transmission of Neisseria
gonorrhoeae and Chlamydia trachomatis are reduced by half with 100% condom use. A recent
report demonstrated a marked reduction of incident HPV infection with consistent condom
use. 5
Despite this evidence, U.S. data indicate that individuals having heterosexual intercourse use
condoms consistently only 19% of the time. 6 Among sexually active adolescents, the highest
risk age group for STDs, only 21% used condoms at last intercourse. One potentially important
factor affecting condom use is that many men are unwilling to use them. Some women may
be unable to negotiate use due to gender-related power imbalances. 7–9
There are few studies in the medical literature that have evaluated patient-specific
characteristics that are associated with vaginal intercourse without barrier method use in
women at risk for STDs and unplanned pregnancy. We sought to address this issue in a baseline
analysis of a randomized trial called Project PROTECT. Our hypothesis was that factors
associated with the number of episodes of intercourse without barrier method use in the past
month would vary by age group. We also hypothesized that specific behavioral and
psychological measures would be associated with vaginal intercourse without barrier method
use during the past month.
MATERIAL AND METHODS
Data for the current study were derived from the baseline data collection efforts of Project
PROTECT - a randomized trial funded by the National Institute of Child Health and Human
Development (NICHD) that evaluated the extent to which a computer-based individualized
intervention could improve dual contraceptive method use. Trial protocols were approved by
the Women and Infants’ Hospital and the University of Rhode Island Institutional Review
Boards.
Women eligible for Project PROTECT included English-speaking women between the ages
of 13 to 35 who were competent to give informed consent. Parental consent and minor assent
were obtained for all participants less than 18 years of age. To be eligible for the study, women
had to report sexual activity with a male partner in the past 6 months; desire to avoid pregnancy
for 24 months after randomization; and test negative for sexually transmitted disease outcomes
of the study (i.e. Chlamydia trachomatis, Neisseria gonorrhoeae, trichomoniasis, and pelvic
inflammatory disease). High-risk women were defined as: 1) all sexually active women age
13 – 24; and 2) sexually active women age 25 – 35 years whose history included any of the
following: unplanned pregnancy; history of an STD; inconsistent use of contraception; or other
factors that placed a woman at above average risk for unplanned pregnancy or STD (e.g., more
than one sexual partner in the past six months or drug or alcohol abuse).
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Recruitment began in October 1999 and continued until October 2003. Potential participants
were recruited from primary care, gynecology, and family planning clinics at the two hospitals
involved in the study, as well as from Planned Parenthood of Rhode Island. Advertisement
was done in local city and university newspapers, on local cable and radio stations, and nurse
recruiters visited local high schools and colleges in the Providence area. Clinicians treating
women tested in clinics or urgent care areas and diagnosed with sexually transmitted infections
were also invited to participate after a negative test of cure. During the study, we also initiated
a “refer-2-friends” program (a.k.a. snowballing) to encourage and improve recruitment. For
this analysis, we were interested in women who were sexually active within the 30 days prior
to their baseline visit. Thus, we limited our analytic sample to a subgroup of 469 women.
At the time of randomization, all participants completed a self-administered questionnaire and
a computer-based survey. The self-administered questionnaire collected information regarding
substance abuse, partner violence, and sexual abuse. The computer intervention inquired about
sexually transmitted disease history, number of sexual partners, frequency of intercourse,
contraceptive behavior including condom use, partner willingness to use condoms, and
participant’s self-efficacy (described below).
The participant’s perception of her male partner’s willingness to use condoms (not at all/not
very/sometimes/extremely willing) was assessed. The psychological construct, self-efficacy,
or a participant’s confidence in her ability to successfully negotiate condom use with her partner
across different challenging situations, was determined using a 10-item scale developed and
validated in different samples by Redding. 10, 11
The two most common measures of condom use have been: proportional (percentage of times
a condom was used) or absolute (the number of times a person reported vaginal intercourse
with condoms over a specified time period). More recent publications support the absolute
measure of condom use. 12–15 As such, we selected as our primary outcome number of
episodes of vaginal intercourse without barrier method use in the past month. We defined
number of episodes vaginal intercourse without barrier method use in last 30 days as:
We dichotomized the outcome into 0–1 episodes of vaginal intercourse without barrier method
use (zero/low risk) versus 2 or more episodes. This dichotomization was based on clinical
relevance with respect to the presumed increased risk of infection with two or more episodes
of vaginal intercourse without barrier method use in a month. Poisson regression analyses were
performed using the number of episodes of vaginal intercourse without barrier method use as
the outcome to support associations noted with the logistic regression.
Bivariate analyses (chi-square for categorical and t-test for continuous variables) evaluated the
association between demographic, reproductive, and sexual history factors and 2 or more
episodes of vaginal intercourse without barrier method use in the past month. Estimates of odds
ratios (OR) and corresponding 95% confidence intervals (CI) were derived from logistic
regression models where the dependent variable was at least 2 acts of vaginal intercourse
without barrier method use in the past 30 days. We also performed logistic regression analyses
stratified by age: women ≥ 19 years-old, women age 20–24, and women age 25 and older.
16 Odds ratios were adjusted for demographic, reproductive, and sexual risk factors. Our final
model included: race/ethnicity, use of hormonal contraception, partner’s willingness to use
condoms, self-efficacy, number of coital acts in the past 30 days, more than one sexual partner
in the past month (yes/no), and having sex after alcohol use. We evaluated model fit with the
use of the C-statistic where values between 0.7 and 0.8 were considered acceptable and values
between 0.8 and 1.0 were considered excellent fit. The C-statistic for the three age groups (≥
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19, 20–24, and ≥ 25) was 0.86, 0.82, and 0.77, respectively. SAS (version 8.2) was used to
perform the statistical analyses.
RESULTS
The demographic, reproductive, and historical characteristics of the study sample are provided
in Table I. The mean age of participants was 21.9 years. Fifty-four percent of the population
was non-white, 25% had less than a high school education, 60% had a history of substance
abuse, 46% had a past STD, and over 50% reported an unplanned pregnancy. Over 50% of the
women in the cohort had six or more lifetime sexual partners and 17% had more than one
sexual partner in the past 30 days.
The following factors differed by age group: education, substance abuse, history of STD or
unplanned pregnancy, hormonal contraception, number of lifetime sexual partners, number of
partners in the past 30 days, number of episodes of sex after alcohol use, and history of
exchanging sex for drugs or money. Higher risk activities were far more common in the older
age group due to the differential eligibility criteria of Project PROTECT for women over 25
years of age.
Sixty-five percent of participants had two or more episodes of vaginal intercourse without
barrier method use in the past 30 days, 11% had one episode, and 24% had zero episodes of
vaginal intercourse without barrier method use. The association between specific
characteristics and having at least two episodes of vaginal intercourse without barrier method
use in the past 30 days is described in Table II. In the unadjusted analysis, hormonal
contraception was associated with an increased odds (OR = 1.8) of at least two episodes of
vaginal intercourse without barrier method use in the past 30 days as was the number of coital
episodes, having three or more occasions of coitus after alcohol use, male partner’s
unwillingness to use condoms, and lower self-efficacy. However, after adjustment for
confounders only the number of coital episodes and the male partner’s unwillingness to use
condoms remained statistically significant in the multivariable model.
Table III provides the associations between reproductive, sexual, behavioral, and psychological
factors and having at least two episodes of intercourse without a barrier in the past 30 days
stratified by age. After adjustment for potential confounders, male partner’s willingness to use
condoms was inversely correlated with at least two episodes of vaginal intercourse without
barrier method use in the past 30 days. The odds of vaginal intercourse without barrier method
use were 6–8 times greater in women with partners not willing to use condoms than in those
with partners willing to use condoms. If partners were “somewhat willing” to use condoms,
there was still a 3 to 5-fold increased odds of having at least two episodes of vaginal intercourse
without barrier method use compared to partners that were very willing to use condoms. Lower
self-efficacy was associated with having at least two episodes of vaginal intercourse without
barrier method use in the past month in women less than 20 years of age, but its effect
diminished in women 20 years of age and older. Hormonal contraception was associated with
increased odds of vaginal intercourse without barrier method use among 20–24 year olds
(ORadj=2.7, 95% CI 1.2–5.0). Regardless of age, race/ethnicity and multiple sexual partners
in the past 30 days were not associated with having vaginal intercourse without barrier method
use.
We performed additional multivariable analysis using Poisson regression as this method does
not rely on an arbitrary dichotomized cutoff of two or more episodes of intercourse without
barrier method use. Poisson regression uses the absolute count (i.e. number of vaginal
intercourse without barrier method use episodes) as the outcome. The findings of these analyses
supported the conclusions reached using logistic regression.
PEIPERT et al. Page 4
Am J Obstet Gynecol. Author manuscript; available in PMC 2008 November 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
COMMENT
There were a number of important observations in this analysis of a group of high-risk,
sexually-active women. Factors strongly associated with having at least two episodes of vaginal
intercourse without barrier method use in the past month included number of coital episodes
and partner’s willingness to use condoms. Use of hormonal contraception was correlated with
having at least two episodes of vaginal intercourse without barrier method use in the past 30
days in women age 20–24, and a women’s confidence in her ability to use condoms (self-
efficacy) was associated with having at least two episodes of vaginal intercourse without barrier
method use in the past month in women age 19 and younger.
Vaginal intercourse without barrier method use in the past month was extremely common in
this sample - 65% of participants reported two or more episodes. In a study of 522 African-
American female adolescents, Crosby found that the mean number of reported acts of
unprotected vaginal sex with a steady partner in the last 6 months was 4.5 (less than one per
month), and the mean number of unprotected vaginal sex acts with a casual partner in the past
6 months was 0.74. 14 There are several potential reasons for the inconsistency across studies.
First, Crosby and colleagues studied a population of African-American female adolescents
(mean age = 16.0 years); over 80% were full-time students. We studied a diverse group of
high-risk women between 13 and 35 years of age. Second, our study focused on the past 30
days, while Crosby and colleagues asked about the previous 6 months. Third, it is possible that
the use of computer-assisted data collection in our study increased the accuracy of reporting
compared to the above study. 17
Consistent with previous literature on the importance of relationship factors for women’s STD
protection, 7–9 the two most important factors associated with having at least two episodes of
vaginal intercourse without barrier method use in the past month in our study, regardless of a
patient’s age, were coital frequency and the male partner’s willingness to use condoms. The
greater the number of coital acts in the past 30 days, the greater the chance of exposure to
pathogens. Coital frequency is an important, and often neglected, aspect of a patient’s sexual
history. Male partner’s unwillingness to use condoms may reflect gender-based power
imbalance. Pulerwitz and colleagues investigated a new measure called the Sexual Relationship
Power Scale (SRPS) and found that women with high levels of relationship power were five
times as likely as women with low levels to report consistent condom use. 18 Other studies
have supported the belief that relationship power is linked to control of contraceptive decision
making. 19–21
Individual self-efficacy was found to be an important correlate of having at least two episodes
of vaginal intercourse without barrier method use in participants less than 20 years old. Self-
efficacy appeared to be most important in adolescents, who are at highest risk for sexually
transmitted diseases. Condom use self-efficacy has also been found to be an important correlate
of condom use in a number of other studies. 22–24 Robertson and colleagues evaluated gender
differences in the prediction of condom use among incarcerated juvenile offenders and noted
that condom use by adolescent males was predicted by peer influence and by positive condom
attitudes. Condom use among females was predicted by peer influence, condom attitudes, and
self-efficacy. 25
In our study, factors associated with having at least two episodes of vaginal intercourse without
barrier method use in the past month varied by age group. Use of hormonal contraception was
associated with a two-fold increased odds of having at least two episodes of vaginal intercourse
without barrier method use in the past month in women age 20–24. In a recent report, Yarnall
and colleagues also noted that use of hormonal contraception was associated with increased
unprotected intercourse. 26 In the U.S., the two most predominant forms of contraception,
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sterilization and oral contraceptives, are highly effective at prevention pregnancy, yet provide
no protection against STDs. Women who use hormonal contraception may be at increased risk
if use is associated with intercourse without barrier method use.
There are a number of methodologic limitations of our baseline analysis that deserve mention.
Condom use was based on self-report. While we attempted to assess consistency of use, we
did not evaluate correct condom use, social norms, or a direct measure of the male’s reported
willingness to use condoms (versus the participant’s assessment of male willingness). In
addition, prospective predictors of intercourse without barrier method use should be evaluated
as prospective predictors may differ from cross-sectional predictors.
Future interventions should focus on STD prevention in women under the age of 25 as this
group is at highest risk for sexually transmitted infections and adverse reproductive outcomes.
27 Numerous studies have noted that interventions should be gender-tailored and culturally
congruent. 22, 28, 29 Interventions should also focus on improving adolescent women’s
condom use self-efficacy. Increased self-efficacy may increase condom use in a relationship,
but only if the male partner is willing to use condoms. As the patient’s partner’s willingness
to use condoms decreases, the likelihood of vaginal intercourse without barrier method use
increases.
Given the power dynamic in many relationships, women often are unable to negotiate the use
of male condoms to protect their health. More empirical exploration of sexual assertiveness
30 and effective strategies to persuade men at different levels of willingness to use condoms
are warranted.
While some investigators and experts in the field have questioned the effectiveness of male
condoms as an effective method of STD prevention, others have emphasized the importance
of male condoms for STD prevention. 31 Winer and colleagues studied 82 university students
who reported their first episode of intercourse with a male partner either during the study period
or within two weeks before enrollment. The incidence of genital HPV was 37.8 per 100 patient-
years in women whose partners used condoms consistently, compared with 89.3 per 100
patient-years at risk in women whose partners used condoms less than 5 percent of the time
(HRadj = 0.3; 95% CI 0.1 to 0.6). 5 Park noted that condom use was protective in women over
the age of 25 years, but had no effect in younger women. 16 It is possible that condom
measurement issues can account for some of the inconsistency across studies. Some
investigators create a binary variable: condom use yes or no. This is a crude measure at best,
and does not assess consistency of use. Others have asked patients to quantify their condom
use on an ordinal scale (e.g. always, almost always, sometimes, etc.) or as a percentage of coital
episodes (e.g. 60 – 80% of coital episodes), but each measure ignores the absolute number of
exposures.
Consistent condom use prevents the acquisition of most viral STDs, such as HIV, and offers
reasonable protection against bacterial STDs. 32 To get a more accurate assessment of the
protective effect of condoms on STD acquisition, it is important that investigators accurately
measure the number of episodes of vaginal intercourse without barrier method use in a time
period. Future intervention studies should carefully assess an absolute measure of exposure to
sexually transmitted pathogens, and evaluate interventions in women to increase their condom
use self-efficacy, condom skills, and social negotiation. In addition, it will be important for
these studies to control for important covariates and potential confounders that can introduce
bias including demographic characteristics, sexual risk factors, contraceptive use, level of
exposure to STD pathogens, and other risk factors that may be associated with STD outcomes.
33 Given the potentially large group of women whose partner(s) may not be willing to use a
male condom, additional prospective studies are needed to assess the role of microbicides and
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female-controlled barriers that could empower women to protect themselves against sexually
transmitted infections.
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Table I
Demographic, reproductive and historical risk factors by age
Total (n=469) ≤ 19 years
(n=132)
20–24 y (n=238) ≥ 25 y (n=99)
Demographic N (%)
Race/ethnicity
 White 218 (46) 64 (48) 116 (49) 38 (38)
 Black 128 (27) 36 (27) 60 (25) 32 (32)
 Hispanic 111 (24) 27 (20) 56 (24) 28 (28)
 Other/Multiracial 170 (36) 42 (32) 89 (37) 39 (39)
Education*
 9th grade or less 44 (9) 18 (14) 10 (4) 16 (16)
 10th – 11th grade 73 (16) 36 (27) 22 (9) 15 (15)
 High school/GED 170 (36) 59 (45) 77 (32) 34 (34)
 2 yr college or more 182 (38) 19 (15) 129 (55) 34 (34)
Substance abuse in last year** 279 (60) 89 (67) 143 (61) 47 (47)
Physical abuse in last year 83 (18) 23 (18) 35 (15) 25 (25)
Forced to have sex in last year 47 (10) 16 (12) 21 (9) 10 (10)
Reproductive
History of STD* 216 (46) 42 (32) 103 (43) 71 (73)
History of unplanned pregnancy* 235 (50) 47 (36) 116 (49) 72 (74)
Current use of hormonal contraception† 159 (34) 40 (31) 95 (40) 24 (25)
Partner’s willingness to use condoms
 Extremely willing 183 (39) 58 (44) 90 (38) 35 (35)
 Somewhat willing 176 (38) 48 (36) 94 (40) 34 (34)
 Not very/not at all willing 66 (14) 17 (13) 29 (12) 20 (20)
 Didn’t know willingness 44 (9) 9 (7) 25 (11) 10 (10)
Sexual history
Lifetime partners**
 1–2 58 (12) 21 (16) 28 (12) 9 (9)
 3–5 166 (35) 60 (45) 78 (33) 28 (28)
 6–10 110 (23) 28 (21) 61 (26) 21 (21)
 11 or more 135 (29) 23 (17) 71 (30) 41 (41)
Number partners past month†
 1 386 (82) 108 (82) 201 (84) 77 (78)
 2 49 (10) 16 (12) 23 (10) 10 (10)
 3 or more 31 (7) 8 (6) 14 (6) 9 (9)
Unplanned sex after drinking (past 30 d) ‡
 Never 199 (42) 60 (45) 86 (36) 53 (54)
 1–2 times 159 (34) 42 (32) 90 (38) 27 (27)
 3 or more times 111 (24) 30 (23) 62 (26) 19 (19)
Ever exchanged sex for drugs or money* 46 (10) 4 (3) 15 (6) 27 (27)
Total no. coital acts
 mean (s.d.) 11.9 (12.6) 12.0 (12.9) 11.4 (11.9) 12.8 (13.9)
 median 9 8 8.5 10
No. unprotected coital acts (30 days)
 mean (s.d.) 7.7 (11.6) 7.7 (12.7) 7.9 (11.6) 7.1 (10.0)
 median 3.0 2.0 4.0 3.0
*
p-value < 0.0001;
**
p-value < 0.01;
†
p-value < 0.05;
‡
p-value = 0.05
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Table II
Association between sociodemographic, reproductive, sexual history variables and at least 2 episodes of vaginal
intercourse without barrier method use in the last 30 days
Episodes of Lack of Barrier Method Use in Last 30 days
Characteristic None or 1 (N=162) % 2 or more (N=307) % Crude OR (95% CI) Adjusted* OR (95% CI)
Age Group
 ≥ 25 years
 20 – 24 years
 ≤ 19 years
35 (22)
75 (46)
52 (32)
64 (21)
163 (53)
80 (26)
Referent
1.19 (0.73–1.95)
0.84 (0.49–1.44)
Referent
1.42 (0.75–2.67)
1.10 (0.54–2.23)
Race/ethnicity
White
Black
Hispanic
Other
75 (46)
46 (28)
37 (23)
53 (33)
143 (47)
82 (27)
74 (24)
117 (38)
Referent
0.97 (0.63 – 1.51)
0.88 (0.49 – 1.57)
1.34 (0.80 – 2.26)
Referent
1.08 (0.62–1.88)
1.04 (0.52–2.09)
0.98 (0.52–1.84)
Substance abuse in last year
 No
 Yes
68 (42)
93 (58)
118 (39)
186 (61)
Referent
1.15 (0.78 – 1.70)
Referent
1.20 (0.70–2.04)
Physically abused in the last year
 No
 Yes
134 (83)
28 (17)
250 (82) 55 (18) Referent 1.05 (0.64 – 1.74) Referent 1.11 (0.58–2.12)
Forced to have sex in last year
 No
 Yes
143 (89)
18 (11)
276 (90)
29 (10)
Referent
0.84 (0.45 – 1.56)
Referent
0.87 (0.39–1.91)
History of STD
 No
 Yes
90 (56)
70 (44)
159 (52)
146 (48)
Referent
1.18 (0.80 – 1.74)
Referent
0.92 (0.55–1.52)
Current use of hormonal contraception
 No
 Yes
119 (74)
42 (26)
188 (62)
117 (38)
Referent
1.76 (1.16 – 2.69)
Referent
1.59 (0.95 – 2.66)
Partner’s willingness to use condoms
 Extremely willing
 Somewhat willing
 Not at all/not very willing
 Don’t know willingness
99 (61)
45 (28)
14 (9)
4 (2)
84 (27)
131 (43)
52 (17)
40 (13)
Referent
3.43 (2.20 – 5.36)
6.02 (3.36 – 10.8)
Referent
3.94 (2.30 – 6.73)
7.57 (3.76 – 15.2)
Other partner past month
 No
 Yes
112 (69)
50 (31)
236 (77)
71 (23)
Referent
0.67 (0.44 – 1.03)
Referent
0.60 (0.35–1.04)
Unplanned sex after drinking (past 30 days)
 Never
 1–2 times
 3 or more times
74 (46)
63 (39)
25 (15)
125 (41)
96 (31)
86 (28)
Referent
0.90 (0.59 – 1.39)
2.04 (1.20 – 3.46)
Referent
0.76 (0.43–1.34)
1.21 (0.58–2.53)
Ever exchanged sex for drugs/money
 No
 Yes
Self Efficacy (Condom Confidence) Mean (s.d.)
148 (91)
14 (9)
39.0 (8.1)
275 (90)
32 (10)
34.4 (10.0)
Referent
1.23 (0.64 – 2.38)
Referent
1.03 (0.43–2.45)
P < 0.0001
Self Efficacy
 High (Score ≥ 40)
 Low (Score < 40)
80 (49)
82 (51)
209 (68)
98 (32)
Referent
2.19 (1.48–3.23)
Referent
1.57 (0.96–2.58)
No. Coital Episodes (past 30 d)
 Median (range)
 Mean (std dev)
3 (1–60)
6.7 (8.5)
10 (2–99)
14.6 (13.6)
1.10 (1.07–1.14) 1.12 (1.08–1.16)
No. Coital Episodes (past 30 d)
 ≤ 8
 9 or more
121 (75)
41 (25)
113 (37)
194 (63)
Referent
5.07 (3.32–7.74)
Referent
5.60 (3.41–9.19)
*
Odds ratios are adjusted for race, use of hormonal contraception, frequency of coitus, more than one partner, partner willingness to use condoms, self-
efficacy, and having unplanned sex after drinking.
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